Article History
Accepted: 22 August 2022
First Online: 1 September 2022
Compliance with Ethical Standards
:
: Victoria Delgado received speaker fees from Abbott Vascular, Edwards Lifesciences, GE Healthcare, Medtronic, Novartis, and MSD; consulting fees from Novo Nordisk and Edwards Lifesciences; and research grants from Abbott Vascular, Edwards Lifesciences, and GE Healthcare. The remaining authors have no conflicts of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.